Parmax Pharma Ltd.BSE: PARMAX

Parmax Pharma Ltd. Press Release Nov 15 2024

· Issued by Parmax Pharma Ltd.

As per regulation 30 and 33 of SEBI (LODR) Regulations, 2015 the board of directors at its meeting held on 14th November, 2024 inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended on 30th September, 2024 along with the Limited Review Report provided by B A Shah S R Mehta, statutory Auditor of the company.

View Attachment